Approval · Notice of Compliance 11079 · 2010
ASACOL: Notice of Compliance 11079
Issued February 22, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11079
- Date
- February 22, 2010
- Company
- Warner Chilcott Canada CoMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Lower gastrointestinal anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ASACOL | 01997580 | Cancelled Post Market |
| ASACOL 800 | 02267217 | Cancelled Post Market |
Medicinal ingredients
- MESALAZINE 400 MG per TAB
- MESALAZINE 800 MG per TAB